| Pharmaceutical active ingredients: |
| Nilutamide |
| Available forms, composition and doses of Nilandron: |
| Tablets; Oral; Nilutamide 150 mgTablets; Oral; Nilutamide 50 mg |
| Nilandron medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L02BB02 - Nilutamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Related documents and information about Nilandron: |
| Nilandron prescribing information (PDF) |